DEPARTMENT OF THE NAVY
OFFICE OF THE CHIEF OF NAVAL OPERATIONS
2000
NAVY PENTAGON
W
ASHINGTON DC 20350-2000
OPNAVINST 9760.1
N95
8 May 2018
OPNAV INSTRUCTION 9760.1
From: Chief of Naval Operations
Subj: HUMAN ELECTRO-MUSCULAR INCAPACITATION DEVICES
Ref: (a) CJCSI 3121.01B (NOTAL)
(b) OPNAVINST 5530.14E
(c) NTTP 3-07.3.2 of February 2015
(d) MARADMIN 560/08, Training and Use of Human Electro-Muscular Incapacitation
Devices
(e) TASER® Instructors Manual (NOTAL)
(f) TASER® User Course (NOTAL)
(g) DoD Directive 3000.3E of 25 April 2013
(h) DoD Directive 2310.01E of 19 August 2014
(i) JAGINST 5800.7F
(j) OPNAVINST F3100.6J (NOTAL)
1. Purpose
a. This instruction implements policy and procedures for the use of human electro-muscular
incapacitation (HEMI) devices throughout the Navy.
b. This revision was performed to update references and provide clarification of mandated
requirements regarding HEMI training and certification, use of HEMI devices, post HEMI
device medical attention, and probe removal. Major change to policy is mandatory medical
attention and continuous monitoring for any person being subdued with a HEMI device. This
instruction is a complete revision and should be reviewed in its entirety.
2. Cancellation. OPNAVINST 3352.1.
3. Scope and Applicability
a. HEMI device employment will be governed by reference (a) and applicable supplemental
rules of engagement (ROE) or rules for the use of force (RUF). In the event of a conflict with
reference (a) or supplemental ROE or RUF, those rules supersede any conflicting policies stated
in this instruction.
